annual accounts payable:
$11.63M+$1.67M(+16.72%)Summary
- As of today (September 16, 2025), SNDX annual accounts payable is $11.63 million, with the most recent change of +$1.67 million (+16.72%) on December 31, 2024.
- During the last 3 years, SNDX annual accounts payable has risen by +$5.96 million (+105.08%).
- SNDX annual accounts payable is now at all-time high.
Performance
SNDX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$17.35M+$7.31M(+72.72%)Summary
- As of today (September 16, 2025), SNDX quarterly accounts payable is $17.35 million, with the most recent change of +$7.31 million (+72.72%) on June 30, 2025.
- Over the past year, SNDX quarterly accounts payable has increased by +$5.79 million (+50.01%).
- SNDX quarterly accounts payable is now at all-time high.
Performance
SNDX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SNDX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.7% | +50.0% |
| 3 y3 years | +105.1% | +169.5% |
| 5 y5 years | +88.2% | +847.2% |
SNDX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +167.3% | at high | +298.9% |
| 5 y | 5-year | at high | +231.4% | at high | +847.2% |
| alltime | all time | at high | +3184.2% | at high | +4271.0% |
SNDX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $17.35M(+72.7%) |
| Mar 2025 | - | $10.05M(-13.6%) |
| Dec 2024 | $11.63M(+16.7%) | $11.63M(+137.4%) |
| Sep 2024 | - | $4.90M(-57.7%) |
| Jun 2024 | - | $11.57M(+31.3%) |
| Mar 2024 | - | $8.81M(-11.6%) |
| Dec 2023 | $9.96M(+129.0%) | $9.96M(+64.7%) |
| Sep 2023 | - | $6.05M(-44.9%) |
| Jun 2023 | - | $10.98M(+36.3%) |
| Mar 2023 | - | $8.06M(+85.2%) |
| Dec 2022 | $4.35M(-23.3%) | $4.35M(-38.9%) |
| Sep 2022 | - | $7.12M(+10.5%) |
| Jun 2022 | - | $6.44M(-21.8%) |
| Mar 2022 | - | $8.23M(+45.2%) |
| Dec 2021 | $5.67M(+61.6%) | $5.67M(+10.7%) |
| Sep 2021 | - | $5.12M(+41.3%) |
| Jun 2021 | - | $3.62M(-44.5%) |
| Mar 2021 | - | $6.53M(+86.1%) |
| Dec 2020 | $3.51M(-43.2%) | $3.51M(-8.6%) |
| Sep 2020 | - | $3.84M(+109.4%) |
| Jun 2020 | - | $1.83M(-79.6%) |
| Mar 2020 | - | $9.00M(+45.6%) |
| Dec 2019 | $6.18M | $6.18M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $6.76M(+196.9%) |
| Jun 2019 | - | $2.28M(-47.7%) |
| Mar 2019 | - | $4.35M(+202.3%) |
| Dec 2018 | $1.44M(-35.5%) | $1.44M(-54.7%) |
| Sep 2018 | - | $3.18M(-40.0%) |
| Jun 2018 | - | $5.30M(+104.5%) |
| Mar 2018 | - | $2.59M(+16.0%) |
| Dec 2017 | $2.23M(-6.0%) | $2.23M(-0.6%) |
| Sep 2017 | - | $2.25M(-33.2%) |
| Jun 2017 | - | $3.36M(+22.7%) |
| Mar 2017 | - | $2.74M(+15.4%) |
| Dec 2016 | $2.38M(+63.6%) | $2.38M(+18.2%) |
| Sep 2016 | - | $2.01M(+26.6%) |
| Jun 2016 | - | $1.59M(-28.6%) |
| Mar 2016 | - | $2.23M(+460.5%) |
| Dec 2015 | $1.45M(+310.2%) | - |
| Dec 2014 | $354.00K(-67.1%) | - |
| Sep 2014 | - | $397.00K(-57.2%) |
| Jun 2014 | - | $928.00K(+15.3%) |
| Mar 2014 | - | $805.00K(-25.3%) |
| Dec 2013 | $1.08M(+38.8%) | $1.08M(+43.2%) |
| Sep 2013 | - | $752.00K |
| Dec 2012 | $776.00K(-4.2%) | - |
| Dec 2011 | $810.00K | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual accounts payable year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual accounts payable?
The current annual accounts payable of SNDX is $11.63M
What is the all time high annual accounts payable for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual accounts payable is $11.63M
What is Syndax Pharmaceuticals, Inc. annual accounts payable year-on-year change?
Over the past year, SNDX annual accounts payable has changed by +$1.67M (+16.72%)
What is Syndax Pharmaceuticals, Inc. quarterly accounts payable?
The current quarterly accounts payable of SNDX is $17.35M
What is the all time high quarterly accounts payable for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly accounts payable is $17.35M
What is Syndax Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
Over the past year, SNDX quarterly accounts payable has changed by +$5.79M (+50.01%)